For the Inventor, By the Inventor

Enter assignee name

Louisville, CO, United States of America

Globeimmune, Inc.

USPTO Granted Patents = 58

CIPO Patents = 48

EPO Patents = 15

Trademarks = 5

Forward Citations = 537

Loading Chart...

Loading Chart...

38 inventors (with patents filed for the assignee):

Alex Franzusoff (29 out of 38 patents)

Thomas H King (26 out of 26 patents)

Zhimin Guo (21 out of 21 patents)

4. David Apelian (21 out of 21 patents)

5. Jeffrey Schlom (14 out of 85 patents)

6. Donald Bellgrau (14 out of 21 patents)

7. Richard C Duke (11 out of 17 patents)

8. Claire Coeshott (8 out of 10 patents)

9. Claudia M Palena (7 out of 13 patents)

10. Aurelia Haller (7 out of 15 patents)

11. Yingnian Lu (4 out of 4 patents)

12. Kwong-Yok Tsang (3 out of 25 patents)

13. James W Hodge (3 out of 14 patents)

14. Cara C Wilson (3 out of 3 patents)

15. Heinrich Röder (2 out of 40 patents)

Core Competencies:

Cellular Immune Responses

Combination Immunotherapy

Yeast-Brachyury Compositions

Yeast-Based Immunotherapy

HIV Infection Treatment

Hepatitis B Virus

Cancer Patient Selection

Chronic Hepatitis C

Yeast-Based Vaccines

Pathogenic Organism Immunity

Tumor Immunotherapy

Mass-Spectral Methods

58 patents: Sort by Forward Citations

1. 12128078 - Lysates of recombinant yeast for inducing cellular immune responses (2024-10-29),

2. 12076382 - Combination immunotherapy compositions against cancer and methods (2024-09-03),

3. 11944673 - Yeast-brachyury immunotherapeutic compositions (2024-04-02),

4. 11938175 - Yeast-brachyury immunotherapeutic compositions (2024-03-26),

5. 11596675 - Combination immunotherapy compositions against cancer and methods (2023-03-07),

6. 11304996 - Yeast-based immunotherapy and type I interferon sensitivity (2022-04-19),

7. 11065318 - Yeast-MUC1 immunotherapeutic compositions and uses thereof (2021-07-20),

8. 11065313 - Modified yeast-brachyury immunotherapeutic compositions (2021-07-20),

9. 10874729 - Combination immunotherapy compositions against cancer and methods (2020-12-29),

10. 10849971 - Compositions and methods for the treatment or prevention of human immunodeficiency virus infection (2020-12-01),

11. 10799567 - Yeast-based immunotherapy and type I interferon sensitivity (2020-10-13),

12. 10722567 - Compositions and methods for the treatment or prevention of tuberculosis (2020-07-28),

13. 10593529 - Mass-spectral method for selection, and de-selection, of cancer patients for treatment with immune response generating therapies (2020-03-17),

14. 10507235 - Yeast-based immunotherapy for Chordoma (2019-12-17),

15. 10441650 - Compositions and methods for the treatment or prevention of hepatitis B virus infection (2019-10-15),

GlobeImmune, Inc. is a biopharmaceutical company focused on developing transformative immunotherapies for the treatment of cancers and infectious diseases. With an innovative approach that combines expertise in immunology and synthetic biology, GlobeImmune is committed to creating novel therapies that improve patient outcomes and quality of life. Through strategic partnerships and cutting-edge research, the company aims to advance the field of immunotherapy and make a lasting impact on global health.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

58 Patents

#6 in Louisville, CO

#111 in Colorado

#5,942 in US

#11,980 in the World

Louisville, CO, United States of America

Globeimmune, Inc.

Forward Citations = 537

38 inventors:

Alex Franzusoff (29 out of 38 patents)

Thomas H King (26 out of 26 patents)

Zhimin Guo (21 out of 21 patents)

4. David Apelian (21 out of 21 patents)

5. Jeffrey Schlom (14 out of 85 patents)

Please report any incorrect information to support@idiyas.com

Loading…